Brendan Rabideau

Brendan Rabideau

PhD Candidate in Health Economics & Policy

Johns Hopkins University

Biography

I am a Ph.D. candidate in Health Economics and Policy in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. My research agenda is focused on understanding how the interaction of health policies and healthcare markets affects access to care, influences patient and provider behaviors, and changes healthcare spending, with a particular focus on behavioral health. My preferred approach is to use large, observational datasets and apply rigorous econometric methods to isolate the causal effects that health policies have on utilization, spending, and health outcomes. My job market paper (linked below) explores the effects of the shift to telemedicine during the COVID-19 pandemic on mental health care utilization, health outcomes, and spending. I will be available for interviews for the 2021-2022 job market.

Interests

  • Health Economics
  • Health Policy / HSR
  • Mental Health
  • Applied Micro

Education

  • PhD in Health Economics & Policy, 2022 (Expected)

    Johns Hopkins University

  • BA in Neuroscience and Philosophy, 2013

    University of Southern California

Working Papers

The Impact of Direct-to-Consumer Advertising on Outpatient Care Utilization

There is much debate about the effects of pharmaceutical direct to consumer advertising (DTCA) on health care use. In this paper, we inform this debate by examining the effects of DTCA on office visits, as well as treatment courses resulting from those visits, for five common chronic conditions (hypertension, hyperlipidemia, diabetes, depression, and osteoporosis). In particular, we examine whether office visits result in use of drug therapy and/or continued office visits over time. We test these questions by combining data on pharmaceutical advertising from Nielsen with claims data from 40 large national employers, covering 18 million person-years (2004-2010). We analyze a non-elderly population by exploiting plausibly exogenous variation in advertising exposure across areas by exploiting the fact that the implementation of Medicare prescription drug coverage led to larger increases in advertising in areas with high elderly share of population compared to low elderly share areas. We find that advertising increases the number of office visits for the non-elderly for the advertised condition. We also find substantial spillovers – a large share of the increased office visits from advertising do not result in use of drugs or are associated with use of generic drugs. Finally, we find that the increase in office visits due to DTCA is associated with multiple consecutive follow up visits over time.

Teaching Assistance

Econometric Methods for Evaluation of Health Programs (PhD)

(with weekly coding lab and discussion section)

Spring 2019, Spring 2020, Spring 2021

Applied Microeconomics for Policymaking (MS/PhD)

Fall 2018, Fall 2019, Fall 2020

Introduction to the U.S. Healthcare System (MS/PhD)

Fall 2019, Spring 2020, Fall 2020